Set to be first utilised in stores, the Cell BioPrint device combines its AI-powered analysis with photos taken of a user’s face to offer up a range of insights, L’Oreal says – including the skin’s ...

While each product featured is independently selected by our editors, we may include paid promotion. If you buy something through our links, we may earn commission. Read more about our Product Review ...

L’Oréal launched a new device called the Cell BioPrint, designed to give people a detailed breakdown of their skin quality in five minutes. The French cosmetics company has long operated at the ...

L'Oreal will double its stake in Swiss skin care firm Galderma to 20%, it said on Monday, potentially earning the French company a bigger cut of profits from the booming market for injectable ...

L’Oréal SA is doubling its stake in Galderma Group AG to 20%, as the French cosmetics and skincare company increases its bet on the maker of injectable fillers that rival Botox.

L'Oreal's Cell BioPrint, unveiled at CES 2025, is designed to take the mystery and frustration out of choosing skin care products. Katie is a UK-based news reporter and features writer. Officially, ...

Choosing skincare products often comes down to a matter of trial and error. A tabletop device unveiled by L’Oréal, called the L’Oréal Cell BioPrint, is intended ...

French skin care giant L’Oréal has agreed to acquire luxury cosmetics brand Aesop, which was founded in Melbourne before developing a cult global following, for an enterprise value of $2.53 billion.

L’Oreal’s (OTCMKTS: LRLCY) total revenue has grown from $27.58 billion in 2016 to $30.95 billion in 2018, on the back of strong demand growth in emerging markets, and higher pricing of their products.

Court revives patents, but rejects UMass' patent interpretation L'Oréal argues its skin creams don't infringe under new interpretation (Reuters) - The University of Massachusetts and a Christian ...